Best buy interventions to address the burden of steatotic liver disease

Lancet Gastroenterol Hepatol. 2024 Nov;9(11):975-977. doi: 10.1016/S2468-1253(24)00220-6. Epub 2024 Sep 3.
No abstract available

MeSH terms

  • Cost of Illness*
  • Fatty Liver / therapy
  • Humans
  • Non-alcoholic Fatty Liver Disease / therapy